Skip to main content
PMC home page
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 1997 Apr-Jun;3(2):195–197. doi: 10.3201/eid0302.970215

Lack of serologic evidence for an association between Cache Valley Virus infection and anencephaly and other neural tube defects in Texas.

J F Edwards 1, K Hendricks 1
PMCID: PMC2627611  PMID: 9204303

Abstract

We tested the hypothesis that Cache Valley Virus (CVV), an endemic North American bunyavirus, may be involved in the pathogenesis of human neural tube defects. This investigation followed a 1990 and 1991 south Texas outbreak of neural tube defects with a high prevalence of anencephaly and the demonstration in 1987 that in utero infection by CVV was the cause of outbreaks of central nervous system and musculoskeletal defects in North American ruminants. Sera from 74 women who gave birth to infants with neural tube defects in south Texas from 1993 through early 1995 were tested for CVV neutralizing antibody. All tested sera did not neutralize CVV. These data suggest that CVV is not involved in the induction of human neural tube defects during nonepidemic periods but do not preclude CVV involvement during epidemics. Other endemic bunyaviruses may still be involved in the pathogenesis of neural tube defects or other congenital central nervous system or musculoskeletal malformations.

Full Text

The Full Text of this article is available as a PDF (17.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albrecht L. J. Mystery in Cameron County. Physicians and health officials search for cause of high rate of anencephaly in the Rio Grande Valley. Tex Med. 1994 Apr;90(4):16–18. [PubMed] [Google Scholar]
  2. Ardinger H. H., Atkin J. F., Blackston R. D., Elsas L. J., Clarren S. K., Livingstone S., Flannery D. B., Pellock J. M., Harrod M. J., Lammer E. J. Verification of the fetal valproate syndrome phenotype. Am J Med Genet. 1988 Jan;29(1):171–185. doi: 10.1002/ajmg.1320290123. [DOI] [PubMed] [Google Scholar]
  3. Brender J. D., Carmichael L., Preece M. J., Larimer G. C., Suarez L. Epidemiology of anencephaly in Texas, 1981-1986. Tex Med. 1989 Jul;85(7):33–35. [PubMed] [Google Scholar]
  4. Calisher C. H., Francy D. B., Smith G. C., Muth D. J., Lazuick J. S., Karabatsos N., Jakob W. L., McLean R. G. Distribution of Bunyamwera serogroup viruses in North America, 1956-1984. Am J Trop Med Hyg. 1986 Mar;35(2):429–443. doi: 10.4269/ajtmh.1986.35.429. [DOI] [PubMed] [Google Scholar]
  5. Calisher C. H., Sever J. L. Are North American Bunyamwera serogroup viruses etiologic agents of human congenital defects of the central nervous system? Emerg Infect Dis. 1995 Oct-Dec;1(4):147–151. doi: 10.3201/eid0104.950409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Campbell L. R., Dayton D. H., Sohal G. S. Neural tube defects: a review of human and animal studies on the etiology of neural tube defects. Teratology. 1986 Oct;34(2):171–187. doi: 10.1002/tera.1420340206. [DOI] [PubMed] [Google Scholar]
  7. Copp A. J., Brook F. A., Estibeiro J. P., Shum A. S., Cockroft D. L. The embryonic development of mammalian neural tube defects. Prog Neurobiol. 1990;35(5):363–403. doi: 10.1016/0301-0082(90)90037-h. [DOI] [PubMed] [Google Scholar]
  8. Edwards J. F. Cache Valley virus. Vet Clin North Am Food Anim Pract. 1994 Nov;10(3):515–524. doi: 10.1016/s0749-0720(15)30536-3. [DOI] [PubMed] [Google Scholar]
  9. Hall J. G. Genetic aspects of arthrogryposis. Clin Orthop Relat Res. 1985 Apr;(194):44–53. [PubMed] [Google Scholar]
  10. Mills J. L., Baker L., Goldman A. S. Malformations in infants of diabetic mothers occur before the seventh gestational week. Implications for treatment. Diabetes. 1979 Apr;28(4):292–293. doi: 10.2337/diab.28.4.292. [DOI] [PubMed] [Google Scholar]
  11. Pantuwatana S., Thompson W. H., Watts D. M., Hanson R. P. Experimental infection of chipmunks and squirrels with La Crosse and Trivittatus viruses and biological transmission of La Crosse virus by Aedes triseriatus. Am J Trop Med Hyg. 1972 Jul;21(4):476–481. doi: 10.4269/ajtmh.1972.21.476. [DOI] [PubMed] [Google Scholar]
  12. Sandford M. K., Kissling G. E., Joubert P. E. Neural tube defect etiology: new evidence concerning maternal hyperthermia, health and diet. Dev Med Child Neurol. 1992 Aug;34(8):661–675. doi: 10.1111/j.1469-8749.1992.tb11502.x. [DOI] [PubMed] [Google Scholar]
  13. Thomas J. A., Markovac J., Ganong W. F. Anencephaly and other neural tube defects. Front Neuroendocrinol. 1994 Jun;15(2):197–201. doi: 10.1006/frne.1994.1008. [DOI] [PubMed] [Google Scholar]
  14. Willett W. C. Folic acid and neural tube defect: can't we come to closure? Am J Public Health. 1992 May;82(5):666–668. doi: 10.2105/ajph.82.5.666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wynne-Davies R., Lloyd-Roberts G. C. Arthrogryposis multiplex congenita. Search for prenatal factors in 66 sporadic cases. Arch Dis Child. 1976 Aug;51(8):618–623. doi: 10.1136/adc.51.8.618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Yen I. H., Khoury M. J., Erickson J. D., James L. M., Waters G. D., Berry R. J. The changing epidemiology of neural tube defects. United States, 1968-1989. Am J Dis Child. 1992 Jul;146(7):857–861. doi: 10.1001/archpedi.1992.02160190089028. [DOI] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES